𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serious Events with Infliximab in Patients with Inflammatory Bowel Disease

✍ Scribed by Hilbert S. de Vries, Martijn G. H. van Oijen, Dr Dirk J. de Jong

Book ID
119929114
Publisher
Springer International Publishing AG
Year
2008
Tongue
English
Weight
116 KB
Volume
31
Category
Article
ISSN
0114-5916

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Are accelerated infliximab infusions saf
Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?
✍ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD